Craig A. Leach
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Peptidase Inhibition and Analysis, Cancer-related Molecular Pathways, Chemokine receptors and signaling, Protein Degradation and Inhibitors
Most-Cited Works
- → A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance(2012)577 cited
- → Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes(2011)393 cited
- → The Ubiquitin-Specific Protease USP34 Regulates Axin Stability and Wnt/β-Catenin Signaling(2011)136 cited
- → Characterization of ubiquitin and ubiquitin‐like‐protein isopeptidase activities(2008)135 cited
- → Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein(2004)113 cited
- → Ubiquitin/SUMO modification of PCNA promotes replication fork progression in Xenopus laevis egg extracts(2005)91 cited
- → Characterization of Selective Ubiquitin and Ubiquitin-Like Protease Inhibitors Using a Fluorescence-Based Multiplex Assay Format(2010)74 cited
- → Regulatory Monoubiquitination of Phosphoenolpyruvate Carboxylase in Germinating Castor Oil Seeds(2008)69 cited
- → RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis(2012)62 cited
- → Targeting the Ubiquitin E3 Ligase MuRF1 to Inhibit Muscle Atrophy(2011)55 cited